Add time:08/08/2019 Source:sciencedirect.com
PurposeZanoterone (100 to 800 mg.) versus placebo was studied in 463 patients with benign prostatic hyperplasia.
We also recommend Trading Suppliers and Manufacturers of Zanoterone (cas 107000-34-0). Pls Click Website Link as below: cas 107000-34-0 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View